Concepedia

Publication | Open Access

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma

DOIFull Paper Access

256

Citations

19

References

2019

Year

Philippe Armand, Scott J. Rodig, Catherine Thiéblemont, Kamal Bouabdallah, Gayane Tumyan, Muhıt Özcan, Sergio Portiño, Laura Maria Fogliatto, Marı́a Dolores Caballero, Jan Walewski,
Journal of Clinical Oncology

Abstract

Pembrolizumab is associated with high response rate, durable activity, and a manageable safety profile in patients with rrPMBCL.

References

YearCitations

Page 1